Dr. Amy E Cox, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |
William Joseph Kovacs, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |
Dr. Shyam Narayana, M.B.B.S, M.P.H Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8395 Fax: 717-531-5726 |
Dr. Ayesha S Siddiqui, M.D Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8395 Fax: 717-531-5726 |
Dr. Ariana R Pichardo-lowden, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8395 Fax: 717-531-5726 |
Nazia Raja-khan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, H088, Hershey, PA 17033 Phone: 717-531-1692 |
Saima Durvesh, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, H088, Hershey, PA 17033 Phone: 717-531-1692 |
Surendra Sivarajah, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8395 Fax: 717-531-5726 |
News Archive
Researchers at the Thorax Centrum Twente of Medisch Spectrum Twente and the University of Twente have recently completed their fourth major study into the application of drug-eluting stents during percutaneous coronary intervention.
Teams at Ludwig-Maximilians-Universitaet in Munich and EMBL have created photosensitive mimics of a class of signaling molecules, thus enabling their actions to be regulated by light, and affording new insights into the communications networks that control cellular metabolism.
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target.
The National Alzheimer's Project Act (NAPA) was signed into law in 2011. Over the past five years milestones have been identified to meet the plan's biomedical research goal. However, similar milestones have not been created for the goals on patient care and caregiver support.
After decades a new drug against malaria has been developed and first clinical trials of this new investigational drug is soon to begin. Enrolment for the same has already started. This study is to be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH). It is to take place at the Duke University School of Medicine in Durham, North Carolina.
› Verified 3 days ago